These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 8389859

  • 1. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.
    Negus SS, Henriksen SJ, Mattox A, Pasternak GW, Portoghese PS, Takemori AE, Weinger MB, Koob GF.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1245-52. PubMed ID: 8389859
    [Abstract] [Full Text] [Related]

  • 2. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M, Goldberg SR.
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [Abstract] [Full Text] [Related]

  • 3. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats.
    Ciccocioppo R, Martin-Fardon R, Weiss F.
    Neuropsychopharmacology; 2002 Sep; 27(3):391-9. PubMed ID: 12225696
    [Abstract] [Full Text] [Related]

  • 4. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK, Meert TF.
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [Abstract] [Full Text] [Related]

  • 5. Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats.
    Gao L, Yu LC.
    Regul Pept; 2004 Aug 15; 120(1-3):53-8. PubMed ID: 15177920
    [Abstract] [Full Text] [Related]

  • 6. Different central opioid receptor subtype antagonists modify maltose dextrin and deprivation-induced water intake in sham feeding and sham drinking rats.
    Leventhal L, Bodnar RJ.
    Brain Res; 1996 Nov 25; 741(1-2):300-8. PubMed ID: 9001736
    [Abstract] [Full Text] [Related]

  • 7. Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats.
    Martin TJ, Kim SA, Cannon DG, Sizemore GM, Bian D, Porreca F, Smith JE.
    J Pharmacol Exp Ther; 2000 Sep 25; 294(3):975-82. PubMed ID: 10945849
    [Abstract] [Full Text] [Related]

  • 8. Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.
    Makino M, Kitano Y, Komiyama C, Hirohashi M, Takasuna K.
    Br J Pharmacol; 2000 Jul 25; 130(6):1269-74. PubMed ID: 10903965
    [Abstract] [Full Text] [Related]

  • 9. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats.
    Hyytiä P, Kiianmaa K.
    Alcohol Clin Exp Res; 2001 Jan 25; 25(1):25-33. PubMed ID: 11198711
    [Abstract] [Full Text] [Related]

  • 10. The effects of highly selective opioid receptor antagonists on the release of arginine vasotocin induced by hyperosmotic stimulation and angiotensin II injection.
    Sasaki T, Arakawa K, Shimada K, Saito N.
    Gen Comp Endocrinol; 2000 Jun 25; 118(3):365-72. PubMed ID: 10843787
    [Abstract] [Full Text] [Related]

  • 11. Antinociceptive effects of galanin in the central nucleus of amygdala of rats, an involvement of opioid receptors.
    Jin WY, Liu Z, Liu D, Yu LC.
    Brain Res; 2010 Mar 12; 1320():16-21. PubMed ID: 20051236
    [Abstract] [Full Text] [Related]

  • 12. Modulation of humoral immune response by central administration of leucine-enkephalin: effects of mu, delta and kappa opioid receptor antagonists.
    Radulović J, Mancev Z, Stanojević S, Vasiljević T, Kovacević-Jovanović V, Pesić G.
    J Neuroimmunol; 1996 Apr 12; 65(2):155-61. PubMed ID: 8964897
    [Abstract] [Full Text] [Related]

  • 13. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J, Zushida K, Ohsawa M, Nagase H.
    Eur J Pharmacol; 2000 Mar 10; 391(1-2):91-6. PubMed ID: 10720639
    [Abstract] [Full Text] [Related]

  • 14. Effects of naltrindole and nor-binaltorphimine treatment on antinociception induced by sub-acute selective mu opioid receptor blockade.
    Walker MJ, Le AD, Poulos CX.
    Brain Res; 1992 Dec 25; 599(2):204-8. PubMed ID: 1337857
    [Abstract] [Full Text] [Related]

  • 15. General, kappa, delta and mu opioid receptor antagonists mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.
    Miner P, Shimonova L, Khaimov A, Borukhova Y, Ilyayeva E, Ranaldi R, Bodnar RJ.
    Brain Res; 2012 Mar 14; 1443():34-51. PubMed ID: 22305145
    [Abstract] [Full Text] [Related]

  • 16. Functional interactions between delta- and mu-opioid receptors in rat thermoregulation.
    Salmi P, Kela J, Arvidsson U, Wahlestedt C.
    Eur J Pharmacol; 2003 Jan 01; 458(1-2):101-6. PubMed ID: 12498912
    [Abstract] [Full Text] [Related]

  • 17. Selective actions of central mu and kappa opioid antagonists upon sucrose intake in sham-fed rats.
    Leventhal L, Kirkham TC, Cole JL, Bodnar RJ.
    Brain Res; 1995 Jul 10; 685(1-2):205-10. PubMed ID: 7583248
    [Abstract] [Full Text] [Related]

  • 18. Conditioned immunomodulation: investigations of the role of endogenous activity at mu, kappa, and delta opioid receptor subtypes.
    Perez L, Lysle DT.
    J Neuroimmunol; 1997 Nov 10; 79(2):101-12. PubMed ID: 9394782
    [Abstract] [Full Text] [Related]

  • 19. Naltrexone in vivo protects mu receptors from inactivation by beta-funaltrexamine, but not kappa receptors from inactivation by nor-binaltorphimine.
    Paronis CA, Waddell AB, Holtzman SG.
    Pharmacol Biochem Behav; 1993 Dec 10; 46(4):813-7. PubMed ID: 8309960
    [Abstract] [Full Text] [Related]

  • 20. Differential involvement of mu-opioid receptors in the rostral versus caudal nucleus accumbens in the reinforcing effects of heroin in rats: evidence from focal injections of beta-funaltrexamine.
    Martin TJ, Kim SA, Lyupina Y, Smith JE.
    Psychopharmacology (Berl); 2002 May 10; 161(2):152-9. PubMed ID: 11981595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.